Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione
This study has been completed.
First Received: September 27, 2005   Last Updated: January 29, 2009   History of Changes
Sponsors and Collaborators: Emory University
National Institutes of Health (NIH)
Information provided by: Emory University
ClinicalTrials.gov Identifier: NCT00228644
  Purpose

Availability of sulfur amino acids (SAA) is critical for glutathione/glutathione disulfide (GSH/GSSG) and cysteine/cystine (CYS/CYSS) redox in vivo and for many other physiologic functions including protein synthesis, nitrogen balance, digestion, osmotic regulation, detoxification, hormonal regulation, biologic methylations, and cell growth regulation. GSH conjugation and sulfate conjugation represent quantitatively important pathways for chemical detoxification, which imposes substantial burden upon SAA supply. The primary hypothesis is that SAA deficient diet and acetaminophen (APAP) administration will perturb Cys metabolism and GSH redox homeostasis in human plasma and urinary output of SAA metabolites. Because both of these variations affect SAA homeostasis, it is believed that the combination of these treatments will produce an interactive effect in which 2-day SAA deficiency will alter APAP metabolism, APAP will affect SAA homeostasis, and the treatments together will alter the global metabolic profile, as measured by 1H-NMR spectroscopy.


Condition
Healthy

MedlinePlus related topics: Diets
Drug Information available for: Acetaminophen CT 2584 Amino acids, branched-chain
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione and Cysteine.

Further study details as provided by Emory University:

Estimated Enrollment: 15
Study Start Date: July 2005
Study Completion Date: January 2009
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Months to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

healthy volunteers

Criteria

Inclusion Criteria:

healthy

Exclusion Criteria:

smokers greater or less than 10% of ideal body weight illness

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00228644

Locations
United States, Georgia
Emory University Hospital
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Dean P Jones, Ph.D. Emory University
  More Information

No publications provided

Responsible Party: Emory University ( Dean Jones, PhD Professor )
Study ID Numbers: 501-2004
Study First Received: September 27, 2005
Last Updated: January 29, 2009
ClinicalTrials.gov Identifier: NCT00228644     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Emory University:
oxidative stress
amino acids
acetaminophen
dietary requirements

Study placed in the following topic categories:
Analgesics, Non-Narcotic
Stress
Peripheral Nervous System Agents
Analgesics
Healthy
Acetaminophen

Additional relevant MeSH terms:
Sensory System Agents
Analgesics, Non-Narcotic
Therapeutic Uses
Physiological Effects of Drugs
Peripheral Nervous System Agents
Analgesics
Central Nervous System Agents
Pharmacologic Actions
Acetaminophen

ClinicalTrials.gov processed this record on May 07, 2009